Gap junctions play a role in the 'bystander effect' of the herpes simplex virus thymidine kinase/ganciclovir system in vitro

Gene Therapy

Volumn 3, Issue 1, 1996, Pages 85-92

  Elshami, A A ^a   Saavedra, A ^a   Zhang, H ^a   Kucharczuk, J C ^a   Spray, D C ^b   Fishman, G I ^b   Amin, K M ^a   Kaiser, L R ^a   Albelda, S M ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

bystander effect; ganciclovir; gap junctions; gene therapy; thymidine kinase

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE; VIRUS VECTOR;

ARTICLE; CANCER CELL; CELL GROWTH; CELL JUNCTION; CELL LINE; CONTROLLED STUDY; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

ADENOVIRUSES, HUMAN; BLOTTING, WESTERN; CONNEXIN 43; FLOW CYTOMETRY; GANCICLOVIR; GAP JUNCTIONS; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HUMANS; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSFECTION; TUMOR CELLS, CULTURED;

HERPES; SIMPLEXVIRUS;

EID: 0029913138     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Moolten FL. Drug sensitivity ('suicide') genes for selective cancer chemotherapy. Cancer Gene Ther 1994; 1: 279-287.
2. Moolten FL, Wells M. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 1990; 82: 297-300.
3. Matthews T, Boehme R. Antiviral activity and mechanism of action of ganciclovir. Rev Infect Dis 1988, 10: S490-S494
4. Samejima Y, Meruelo D. 'Bystander killing' induces apoptosis and is inhibited by forskolin. Gene Therapy 1995; 2: 50-58.
5. Clinical protocols. Cancer Gene Ther 1995; 2: 67-74.
6. Culver KW et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550-1552.
7. Freeman SM et al. The 'bystander effect': tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53: 5274-5283.
8. Ram Z et al. In situ retroviral-mediated gene transfer for the treatment of brain rumors in rats. Cancer Res 1993; 53: 83-88.
9. Barba D, Hardin J, Sadelain M, Gage FH. Development of antirumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci USA 1994; 91: 4348-4352.
10. Smythe WR et al. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res 1994; 54: 2055-2059.
11. Kolberg R. The bystander effect in gene therapy: great but how does it work? J Natl Inst Health Res 1994; 6: 62-64.
12. Li Bi W, Parysek LM, Warnick R, Stambrook PJ. In vivo evidence that metabolic cooperation Ls responsible for the bystander effect observed with HSVtk retroviral gene therapy. Hum Gene Ther 1993, 4. 725-731.
13. Moreno AP, Laing JG, Beyer EC, Spray DC. Properties of gap junction channels formed of connexin 45 endogenously expressed in human hepatoma (SKHep1) cells. Am J Physiol 1995; 268: 356-365.
14. Fishman GI, Spray DC, Leinwand LA. Molecular characterization and functional expression of the human cardiac gap junction channel. J Cell Biol 1990; 111: 589-598.
15. Fishman GI, Gao Y, Hertzberg EL, Spray DC. Reversible intercellular coupling by regulated expression of a gap junction channel gene. Cell Adhes Commun 1995 (in press).
16. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
17. Eghbali B et al. Involvement of gap junctions in tumorigenesis: transfection of tumor cells with connexin 32 cDNA retards growth in vivo. Proc Natl Acad Sci USA 1991; 88: 10701-10705.
18. Tomasetto C et al. Specificity of gap junction communication among human mammary cells and connexin transfectants in culture. J Cell Biol 1993; 122: 157-167.
19. Dickerman LH, Tischfield JA. Comparative effects of adenine analogs upon metabolic cooperation between hamster cells with different levels of adenine phosphoribosyltransference activity. Mutat Res 1978: 49: 83-94.
20. Subak-Sharpe JH, Burk RR, Pitts JD. Metabolic cooperation between biochemically marked mammalian cells in tissue culture. J Cell Sci 1969; 4: 353-367.
21. Bennett MVL et al. Gap junctions: new tools, new answers, new questions (review). Neuron 1991; 6: 305-320.
22. Ram Z et al. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J Neurosurg 1994; 81: 256-260.
23. Mehta PP, Loewenstein WR. Differential regulation of communication by retinoic acid in homologous and heterologous junctions between normal and transformed cells. J Cell Biol 1991; 113: 371-379
24. Doerr R et al. Clonal growth of tumors on tissue-specific biomatrices and correlation with organ site specificity of metastases. Cancer Res 1989; 49: 384-392.
25. Smythe WR et al. Successful adenovirus-mediated gene transfer in an m vivo model of human malignant mesothelioma. Ann Thor Surg 1994; 57: 1395-1401.
26. Englehardt JF et al. Direct gene transfer of human CFlK into human bronchial epithelia of xenografts with El-deleted adenoviruses. Nat Genet 1993; 4: 27-34.
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
28. Alley MC et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988; 48: 589-601.